Tracking down lung diseases by finding the causes and developing novel therapies.
Since 2010 scientists at the Ludwig Boltzmann Institute for Lung Vascular Research (LBI-LVR) have been on the track of lung diseases such as the life-threatening pulmonary hypertension. Today, the LBI-LVR, an institute of the Ludwig Boltzmann Society, is among the leading international institutes in the field of lung vascular research. Not least, this can be attributed to the unique interdisciplinary cooperation between basic researchers and physicians.
Biologists, chemists, medical professionals, pharmacologists, physicists and many other scientists at the LBI-LVR investigate lung diseases within three complementary research units: molecular and pharmacologic strategies for reverse remodelling of the pulmonary circulation, non-invasive assessment of the pulmonary circulation and the establishment of a comprehensive clinical database.
The scientists at the LBI-LVR are working together on decoding lung diseases with great commitment to understand the causes and the progression of these diseases as well as to provide the basis for more precise and safer therapies which finally should lead to a better life quality of the patients.
Newsletter of the Pulmo-Outpatient Clinic of the Hospital Graz and the Ludwig Boltzmann Institute for Lung Vascular Research for patients with pulmonary hypertension or a high risk for this disease.
The first issue was sent to the patients in May 2014. If you are interested, you can receive it via email or mail: Please, contact Daniela Kleinschek.